Table 1 Summary of analyzed TCGA cancer types and data sets
From: Analysis of microRNA-target interactions across diverse cancer types
Cancer type | Description | Samples | miRNAs | mRNAs |
---|---|---|---|---|
GBM | Glioblastoma multiforme | 380 | 446 | 17,805 |
OVA | Ovarian serous cystadenocarcinoma | 509 | 589 | 17,805 |
CRCb | Colon and rectum adenocarcinoma | 181 | 347 | 15,855 |
KIRC | Kidney renal clear-cell carcinoma | 368 | 376 | 18,213 |
LUSC | Lung squamous-cell carcinoma | 195 | 439 | 18,135 |
BRCA | Breast invasive carcinoma | 671 | 419 | 18,099 |
UCEC | Uterine corpus endometrioid carcinoma | 247 | 498 | 15,897 |
BLCA | Bladder urothelial carcinoma | 94 | 507 | 15,377 |
HNSC | Head and neck squamous-cell carcinoma | 298 | 463 | 15,140 |
LUAD | Lung adenocarcinoma | 347 | 472 | 15,455 |
Total | Â | 3,290 | 429a | 16,190a |